The new drug activates special antibodies, which subsequently block the development of infection.
Scientists from the Duke Institute in the United States have created a new vaccine against all dangerous types of coronavirus infection. The drug has already been tested in preclinical trials.
It is noted that the vaccine, using nanoparticles, activates antibodies consisting of fragments of coronavirus and adjuvan.
- Scientists in Fear of This New Predator From Red Sea Eating Native Species in Mediterranean
- Does This Mean We Stopped Being Animal and Started Being Human Due to ‘Copy Paste’ Errors?
- The One Lifestyle Choice That Could Reduce Your Heart Disease Risk By More Than 22%
- Aging: This Is What Happens Inside Your Body Right After Exercise
- Immune-Boosting Drink that Mimics Fasting to Reduce Fat – Scientists ‘Were Surprised’ By New Findings
The latter is a special binding agent that enhances the immune response to the ingress of an immunogen into the human body.
Tests on macaques and mice have shown that in this way, different strains of coronavirus infection, including SARS-CoV-2, can be successfully neutralized by 100%.
Researchers claim that the new vaccine is many times more effective at neutralizing the infection than currently used.
The results of the study, yet to be peer reviewed, are published in the scientific journal Nature.
Image Credit: iStock